Natalizumab and progressive multifocal leucoencephalopathy

被引：39

作者：

Berger, J. R. ^{[1
]}

机构：

[1] Univ Kentucky, Coll Med, Dept Neurol, Kentucky Clin L 445, Lexington, KY 40536 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷

关键词：

D O I：

10.1136/ard.2006.058404

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Current data suggest that as many as 1 in 1000 treated individuals may develop progressive multifocal leucoencephalopathy (PML) in concert with the use of natalizumab. Natalizumab was withdrawn in early 2005. The present paper provides a comprehensive description of PML and reviews the role of natalizumab in the pathogenesis of PML. It is likely that use of drugs which cause specific perturbations of the immune system will be accompanied by similar rare infections. Thus researchers should be on the alert when using such agents in clinical trials.

引用

页码：48 / 53

页数：6

共 95 条

[1] Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy [J].

Albrecht, H ;

Hoffmann, C ;

Degen, O ;

Stoehr, A ;

Plettenberg, A ;

Mertenskötter, T ;

Eggers, C ;

Stellbrink, HJ .

AIDS, 1998, 12 (10) :1149-1154

[2] Activities of various compounds against murine and primate polyomaviruses [J].

Andrei, G ;

Snoeck, R ;

Vandeputte, M ;

DeClercq, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :587-593

[3] Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy [J].

Andréoletti, L ;

Lescieux, A ;

Lambert, V ;

Si-Mohamed, A ;

Matta, M ;

Wattré, P ;

Bélec, L .

JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (01) :1-7

[4] Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era [J].

Antinori, A ;

Ammassari, A ;

Giancola, ML ;

Cingolani, A ;

Grisetti, S ;

Murri, R ;

Alba, L ;

Ciancio, B ;

Soldani, F ;

Larussa, D ;

Ippolito, G ;

De Luca, A .

JOURNAL OF NEUROVIROLOGY, 2001, 7 (04) :323-328

[5] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY - A HITHERTO UNRECOGNIZED COMPLICATION OF CHRONIC LYMPHATIC LEUKAEMIA AND HODGKINS DISEASE [J].

ASTROM, KE ;

MANCALL, EL ;

RICHARDSON, EP .

BRAIN, 1958, 81 (01) :93-&

[6] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AND CYTARABINE - REMISSION WITH TREATMENT [J].

BAUER, WR ;

TUREL, AP ;

JOHNSON, KP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 226 (02) :174-196

[7]

BERGER J, 1999, TXB AIDS MED, P403

[8] Progressive multifocal leukoencephalopathy and natalizumab - Unforeseen consequences [J].

Berger, JR ;

Koralnik, IJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04) :414-416

[9] Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate, frequency of the illness relative to other immunosuppressive conditions [J].

Berger, JR .

JOURNAL OF NEUROVIROLOGY, 2003, 9 (Suppl 1) :38-41

[10] Progressive multifocal leukoencephalopathy in patients with HIV infection [J].

Berger, JR ;

Pall, L ;

Lanska, D ;

Whiteman, M .

JOURNAL OF NEUROVIROLOGY, 1998, 4 (01) :59-68

← 1 2 3 4 5 6 7 8 9 10 →